Design Therapeutics, Inc.

The current price of DSGN is 3.65 USD — it has decreased by 0.27% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Design Therapeutics, Inc. stocks are traded under the ticker DSGN.

Design Therapeutics, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.

DSGN stock is 4.93% volatile and has beta coefficient of 3.23. Check out the list of the most volatile stocks — is Design Therapeutics, Inc. there?

DSGN earnings for the last quarter are −0.28 USD per share, whereas the estimation was −0.41 USD resulting in a 31.29% surprise. The estimated earnings for the next quarter are −0.31 USD per share. See more details about Design Therapeutics, Inc. earnings.

Yes, you can track Design Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

DSGN stock has fallen by 1.62% compared to the previous week, the month change is a 3.95% fall, over the last year Design Therapeutics, Inc. has showed a 40.84% decrease.

Today Design Therapeutics, Inc. has the market capitalization of ‪206.20 M‬, it has increased by 5.42% over the last week.

No, DSGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, DSGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Design Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

DSGN reached its all-time high on Mar 26, 2021 with the price of 50.50 USD, and its all-time low was 1.94 USD and was reached on Aug 22, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 124.00 employees. See our rating of the largest employees — is Design Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Design Therapeutics, Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Design Therapeutics, Inc. stock shows the sell signal. See more of Design Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Design Therapeutics, Inc. future price: according to them, DSGN price has a max estimate of 6.00 USD and a min estimate of 4.00 USD. Read a more detailed Design Therapeutics, Inc. forecast: see what analysts think of Design Therapeutics, Inc. and suggest that you do with its stocks.